NVCN Relative Valuation - Neovasc Inc

Watchlist Manager

Watchlist

Price: 40.15 CAD Market Closed

Market Cap: CA$110.8m

Relative Value

There is not enough data to reliably calculate the relative value of NVCN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

NVCN Relative Value

Base Case

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CA	Neovasc Inc TSX:NVCN	110.5m CAD	21.3	-2	-2.1	-2
US	Abbott Laboratories NYSE:ABT	189.6B USD	4.3	29.1	16.5	22.5
US	Intuitive Surgical Inc NASDAQ:ISRG	171B USD	17	59.8	45.5	55.1
US	Stryker Corp NYSE:SYK	138.8B USD	5.5	42.9	21.7	26.3
IE	Medtronic PLC NYSE:MDT	132.5B USD	3.8	27.8	15.6	22.5
US	Boston Scientific Corp NYSE:BSX	115.7B USD	6	41.5	24.6	33.5
US	Becton Dickinson and Co NYSE:BDX	58.8B USD	2.7	35.1	12.8	21.9
DE	Siemens Healthineers AG XETRA:SHL	46.4B EUR	2	22	12.5	17.6
US	IDEXX Laboratories Inc NASDAQ:IDXX	51.8B USD	12	48.7	34.8	38.4
US	Edwards Lifesciences Corp NYSE:EW	45.4B USD	7.7	33.2	23.6	25.8
US	Resmed Inc NYSE:RMD	39B USD	7.2	26.2	18.5	20.6

			Revenue Growth	P/S to Growth
CA	Neovasc Inc TSX:NVCN	Average P/S: 8.1 21.3	N/A	N/A
US	Abbott Laboratories NYSE:ABT	4.3	8%	0.5
US	Intuitive Surgical Inc NASDAQ:ISRG	17	14%	1.2
US	Stryker Corp NYSE:SYK	5.5	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.8	7%	0.5
US	Boston Scientific Corp NYSE:BSX	6	14%	0.4
US	Becton Dickinson and Co NYSE:BDX	2.7	4%	0.7
DE	Siemens Healthineers AG XETRA:SHL	2	6%	0.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	12	10%	1.2
US	Edwards Lifesciences Corp NYSE:EW	7.7	11%	0.7
US	Resmed Inc NYSE:RMD	7.2	8%	0.9

			Earnings Growth	PEG
CA	Neovasc Inc TSX:NVCN	Average P/E: 36.6 Negative Multiple: -2	N/A	N/A
US	Abbott Laboratories NYSE:ABT	29.1	22%	1.3
US	Intuitive Surgical Inc NASDAQ:ISRG	59.8	18%	3.3
US	Stryker Corp NYSE:SYK	42.9	30%	1.4
IE	Medtronic PLC NYSE:MDT	27.8	22%	1.3
US	Boston Scientific Corp NYSE:BSX	41.5	47%	0.9
US	Becton Dickinson and Co NYSE:BDX	35.1	42%	0.8
DE	Siemens Healthineers AG XETRA:SHL	22	17%	1.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	48.7	12%	4.1
US	Edwards Lifesciences Corp NYSE:EW	33.2	-23%	N/A
US	Resmed Inc NYSE:RMD	26.2	11%	2.4

			EBITDA Growth	EV/EBITDA to Growth
CA	Neovasc Inc TSX:NVCN	Average EV/EBITDA: 22.6 Negative Multiple: -2.1	N/A	N/A
US	Abbott Laboratories NYSE:ABT	16.5	9%	1.8
US	Intuitive Surgical Inc NASDAQ:ISRG	45.5	24%	1.9
US	Stryker Corp NYSE:SYK	21.7	12%	1.8
IE	Medtronic PLC NYSE:MDT	15.6	8%	1.9
US	Boston Scientific Corp NYSE:BSX	24.6	22%	1.1
US	Becton Dickinson and Co NYSE:BDX	12.8	8%	1.6
DE	Siemens Healthineers AG XETRA:SHL	12.5	11%	1.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	34.8	11%	3.2
US	Edwards Lifesciences Corp NYSE:EW	23.6	13%	1.8
US	Resmed Inc NYSE:RMD	18.5	11%	1.7

			EBIT Growth	EV/EBIT to Growth
CA	Neovasc Inc TSX:NVCN	Average EV/EBIT: 28.4 Negative Multiple: -2	N/A	N/A
US	Abbott Laboratories NYSE:ABT	22.5	17%	1.3
US	Intuitive Surgical Inc NASDAQ:ISRG	55.1	25%	2.2
US	Stryker Corp NYSE:SYK	26.3	16%	1.6
IE	Medtronic PLC NYSE:MDT	22.5	17%	1.3
US	Boston Scientific Corp NYSE:BSX	33.5	32%	1
US	Becton Dickinson and Co NYSE:BDX	21.9	21%	1
DE	Siemens Healthineers AG XETRA:SHL	17.6	15%	1.2
US	IDEXX Laboratories Inc NASDAQ:IDXX	38.4	11%	3.5
US	Edwards Lifesciences Corp NYSE:EW	25.8	14%	1.8
US	Resmed Inc NYSE:RMD	20.6	12%	1.7

Neovasc Inc
TSX:NVCN

Relative Value

Valuation Multiples

Multiples Across Competitors

NVCN Competitors Multiples
Neovasc Inc Competitors

See Also

Company

Help

Tools

Stocks

Neovasc Inc TSX:NVCN

Relative Value

Valuation Multiples

Multiples Across Competitors

NVCN Competitors Multiples Neovasc Inc Competitors

See Also

Company

Help

Tools

Stocks

Neovasc Inc
TSX:NVCN

NVCN Competitors Multiples
Neovasc Inc Competitors